Many people across the United Kingdom are experiencing a enigmatic and incapacitating skin disorder that has left the medical profession baffled. Sufferers report their skin becoming intensely inflamed with cracking and peeling, often across their entire bodies, yet many doctors find it difficult to diagnose and treat the condition. The phenomenon, called topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on online platforms, with footage showing patients’ experiences garnering over a billion views on TikTok alone. Even though it impacts a growing number of people, TSW remains so poorly understood that some doctors and dermatologists query whether it actually exists at all. Now, for the very first time, researchers across the UK are commencing a major study to determine what is behind these mysterious symptoms and how some people come to develop the condition whereas others do not.
The Puzzling Condition Spreading Across the UK
Bethany Gamble’s story exemplifies the profound effects of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had controlled her eczema well with steroid creams since childhood, but at eighteen, her condition deteriorated significantly. Her skin became intensely inflamed and red, splitting and weeping whilst the itching became what she describes as “bone deep”. Within two years, the pain had become so acute that she was unable to leave her bed, dependent on continuous support from her mother. Most troubling, Bethany experienced repeated dismissal by doctors who attributed her symptoms to standard eczema and continued prescribing the very treatments she thought were responsible for her suffering.
The healthcare sector remains divided on how to manage TSW, with deep divisions about its core nature. Some experts regard it as a severe allergic response to the topical steroids that form the first-line treatment for eczema across the NHS. Others contend it represents a acute flare-up of pre-existing skin conditions rather than a distinct syndrome, whilst a small number doubt of its existence altogether. This professional uncertainty has placed patients like Bethany stuck in a diagnostic uncertainty, finding it hard to obtain appropriate treatment. The absence of agreement has encouraged Professor Sara Brown at the Edinburgh University to create the first significant UK research initiative examining TSW, funded by the National Eczema Society.
- Symptoms include significant swelling, skin fissuring and intense itching across the body
- Patients describe “elephant skin” hardening and extreme shedding of dead skin cells
- Medical professionals commonly disregard TSW as standard eczema or decline to recognise it
- The condition can be so incapacitating that sufferers find themselves unable to carry out everyday tasks
Living with Steroid Topical Withdrawal
From Controllable Eczema to Severe Symptoms
For many sufferers, withdrawal from topical steroids constitutes a severe decline from a formerly stable skin condition. What starts with occasional itching in skin creases can rapidly escalate into a widespread inflammatory reaction that leaves patients unable to function. The transition often occurs suddenly, without warning, converting a manageable chronic condition into an acute medical crisis. People describe their skin turning intensely hot, red and inflamed, with severe cracking and weeping that demands constant attention. The physical toll is worsened by exhaustion, as the relentless itching disrupts sleep and healing, creating a vicious cycle of decline.
The rate at which TSW develops takes many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the severity of symptoms that appear when their condition suddenly worsens. Routine activities become overwhelming difficulties: showering becomes excruciating, dressing demands help, and preserving hygiene demands considerable exertion. Some patients describe feeling as though their skin is under assault from within, with inflammation moving through their body in patterns that show little similarity to their earlier flare-ups. This marked shift often drives sufferers to obtain emergency care, only to face doubt from healthcare professionals.
The Fight for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the medical gaslighting that frequently accompanies it. Patients presenting with serious, unexplained health issues are routinely told they simply have eczema worsening, despite their insistence that this is fundamentally different from anything they’ve experienced before. Doctors often respond by recommending higher-strength steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This pattern of rejection leaves sufferers feeling abandoned by the healthcare system, forced to navigate their illness alone whilst being told their lived experience is invalid. Many patients report feeling gaslit repeatedly, their worries disregarded as emotional or psychological in nature rather than genuine physiological symptoms.
The lack of professional agreement has established a significant divide between patient experience and clinical acknowledgement. Without clear diagnostic criteria or established treatment protocols, general practitioners and skin specialists find it difficult to diagnose TSW or offer appropriate support. Some clinicians remain completely sceptical the disorder is real, treating all severe presentations as standard eczema or other known dermatological conditions. This clinical doubt results in delayed diagnosis, inappropriate treatment and profound psychological distress for patients already suffering physically. The growing visibility of TSW on social media has drawn attention to this diagnostic void, encouraging investigation to examine the experiences reported by vast numbers of individuals, even as the healthcare profession continues to disagree on how to respond.
- Symptoms can emerge abruptly in individuals with previously stable eczema managed by topical steroids
- Patients often face disbelief from healthcare professionals who attribute worsening to typical eczema exacerbations
- Healthcare providers continue to disagree on whether TSW is a genuine condition or severe eczema exacerbation
- Lack of diagnostic criteria means many sufferers struggle to access appropriate treatment and assistance
- Online platforms has amplified voices of patients, with TSW hashtags reaching more than one billion views globally
Racial Disparities in Diagnosis and Care
The diagnostic difficulties surrounding topical steroid withdrawal become more acute amongst individuals with darker skin, where symptoms can be significantly harder to identify visually. Erythema and inflammatory responses, the defining features of TSW in people with lighter skin, manifest differently across various ethnicities, yet many clinical guidelines remain focused on how the condition appears in white patients. This gap means that Black, Asian and other people of colour experiencing TSW commonly experience even greater delays in identification and acceptance. Medical staff trained primarily on presentations in lighter skin may miss or misread the defining features, causing additional diagnostic errors and inappropriate treatment recommendations that can exacerbate suffering.
Research into TSW has historically overlooked the experiences of people with deeper skin tones, perpetuating a cycle where their condition goes insufficiently documented and inadequately researched. The social media conversations dominating TSW discussions have been predominantly influenced by voices with lighter skin, potentially skewing medical understanding and community understanding. As Professor Sara Brown’s groundbreaking UK study progresses, ensuring diverse representation amongst participants will be crucial to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without intentional action to prioritise the perspectives of all ethnic groups, treatment inequalities in TSW identification and care risk widening further, leaving vulnerable populations without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Treatment and Research Approaches Coming to Light
Initial Major UK Study Underway
Professor Sara Brown’s groundbreaking research at the Edinburgh University constitutes a significant milestone for TSW sufferers pursuing validation and clarity. Funded by the National Eczema Society, the study has brought together numerous participants throughout the United Kingdom to investigate the underlying mechanisms driving topical steroid withdrawal. By analysing symptoms, saliva samples and skin biopsies, researchers seek to identify why some people experience TSW whilst others on identical steroid regimens do not. This scientific scrutiny marks a important transition from dismissal to serious investigation.
The investigative group partnering with Dr Alice Burleigh from patients’ support organisation Scratch That, brings both clinical knowledge and lived experience to the investigation. Their partnership approach accepts that patients hold essential understanding into their medical conditions. Professor Brown has noted patterns in TSW that defy explanation by standard eczema knowledge, including marked “elephant skin” thickening, severe shedding and sharply demarcated zones of inflammation. The research findings could fundamentally reshape how doctors handle diagnosis and care of this debilitating condition.
Available Treatments and Associated Limitations
At present, treatment options for TSW are quite limited and frequently inadequate. Many clinicians continue prescribing topical steroids despite evidence suggesting they may exacerbate symptoms in vulnerable patients. Some patients report temporary relief from emollients, antihistamines and systemic medications, though outcomes differ significantly. Dermatologists are split on best treatment approaches, with some advocating complete steroid cessation whilst others advocate phased withdrawal. This absence of agreement forces patients to navigate their treatment journeys predominantly by themselves, depending significantly on peer support networks and web-based forums for advice.
Psychological support and specialist dermatological care offer potential benefits, yet access is inconsistent across the NHS. Some patients have explored alternative approaches including changes to diet, environmental controls and holistic therapies, though scientific evidence supporting these interventions is limited. The lack of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollient creams and hydrating products to enhance skin barrier function and reduce water loss
- Antihistamines to control itching and related sleep disruption in flare episodes
- Oral corticosteroids or immunosuppressants for serious presentations with specialist oversight
- Psychological counselling to tackle trauma and anxiety related to prolonged skin suffering
Testimonies of Aspiration and Perseverance
Despite the uncertainty regarding TSW and the frequently dismissive perspectives from healthcare professionals, patients are drawing strength in shared community and shared experience. Digital support communities have proven vital for those struggling with the disorder, offering practical guidance and validation when conventional medicine has let them down. Many individuals affected recount the moment they discovered the TSW hashtag as transformative—finally finding others with identical symptoms and recognising they were not alone in their experience. This collective voice has been powerful enough to prompt the first serious research efforts, demonstrating that patient-led campaigns can advance medical understanding even when institutional structures remain sceptical.
Bethany Gamble and those facing comparable challenges are determined to draw attention and campaign for proper recognition of TSW within the medical establishment. Their openness in share deeply personal accounts of their struggles on social media has normalised conversations around a condition that many doctors still are unwilling to accept. These individuals are not sitting idly for responses; they are actively participating in scientific investigations, tracking their signs carefully, and demanding that their experiences be treated with respect. Their resilience in the midst of persistent distress and dismissive healthcare practices provides encouragement that responses might prove to be within attainment, and that those to come will be given the recognition and support they urgently require.
- Community-driven research projects are filling gaps overlooked by conventional healthcare systems and advancing knowledge of TSW
- Online communities provide psychological assistance, practical coping strategies, and mutual recognition for affected individuals worldwide
- Advocacy efforts are gradually shifting clinical attitudes, encouraging dermatologists to examine rather than overlook patient concerns
